TLDR: Researchers from Hamad Bin Khalifa University (HBKU) have introduced a ‘True Lifecycle Approach’ (TLA) for governing Artificial Intelligence (AI) in healthcare. This new model aims to ensure AI is safely and ethically integrated across all stages of its development and deployment, prioritizing patient well-being and addressing current regulatory gaps.
Doha, Qatar – A groundbreaking ‘True Lifecycle Approach’ (TLA) for the governance of Artificial Intelligence (AI) in healthcare has been proposed by researchers from the College of Law at Hamad Bin Khalifa University (HBKU). This innovative model seeks to address the complex ethical and regulatory challenges posed by AI’s rapid integration into the medical field, while fostering a more robust and patient-centric framework.
Dr. Barry Solaiman, assistant professor of law and associate dean for academic affairs at HBKU’s College of Law, articulated the core philosophy of TLA in a recent article published in Diplomatic Courier, a global affairs media network. According to Dr. Solaiman, the TLA is ‘premised on the idea that AI should be governed across all stages of its research, design, implementation, and oversight.’ He emphasized, ‘At its heart is a simple concept: patients must come first.’
The proposal highlights a critical gap in existing AI governance frameworks, which are often fragmented and struggle to keep pace with technological advancements. Current approaches tend to focus narrowly on the approval of AI medical devices for market entry, overlooking crucial aspects such as informed consent, malpractice liability, and broader patient rights. Dr. Solaiman noted that these frameworks often perceive AI merely as a technical tool, rather than recognizing its profound impact on human lives.
The TLA advocates for a more comprehensive regulatory scope, granting regulators broader powers to ensure healthcare AI meets stringent safety standards. It mandates that governance rules extend beyond just researchers and developers to encompass all downstream entities utilizing AI, including healthcare providers and insurers. This holistic approach is particularly pertinent as GCC countries, including Qatar, are significantly investing in AI, with a strong focus on healthcare applications.
Also Read:
- States Forge Ahead with AI Governance Amidst Federal Regulatory Vacuum
- AI Wearables Revolutionize Public Health Amidst Governance Debates and Shifting Investment Landscape
Dr. Solaiman underscored the human element of AI development, stating that ‘AI is not just a technological project but a human one.’ He stressed the importance of embedding medical law and ethics throughout the governance process, ensuring that the patient remains at the forefront of all considerations. The TLA aims to provide a much-needed framework to ensure AI in healthcare is safe, ethical, and worthy of patients’ trust, moving beyond the limitations of current regulatory bodies.
